Ingenox Therapeutics Limited
14127227
Some Concerns
- Negative net worth (-10)
- Current liabilities exceed current assets (-10)
Details
Compliance
Accounts
Confirmation statement
Industry
Officers
director · Since 24/05/2022
CHIEF EXECUTIVE OFFICER
BRITISH · UNITED KINGDOM · Age 68
Also on 6 other boards
director · Since 19/04/2024
COMPANY DIRECTOR
AMERICAN · UNITED STATES · Age 67
Also on 1 other board
Persons with Significant Control
Patrick Soon-Shiong
American · United States · Age 73
Magdalen Centre Robert Robinson Avenue, Oxford Science Park, Oxford, OX4 4GA
Notified 19/04/2024
Former PSCs
Prof Nicholas Barrie La Thangue
Ceased 22/12/2022
CompanyRankvs 42359+ SIC 64209 peers38
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/12/2024
Net Worth
-£5.2M
Balance sheet strength
Cash
£1.0M
Cash in the bank
Net Current Assets
£775k
Working capital
Current Assets
£1.6M
Current Liabilities
£850k
Fixed Assets
£1.6M
Debtors
£585k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2024 | 1.91 |
Derived from filed accounts. Not audited figures.